IL-6 and TNF-α expression in, and release from, contracting human skeletal muscle

American Journal of Physiology - Endocrinology and Metabolism

Volumn 283, Issue 6 46-6, 2002, Pages

  Steensberg, Adam ^a,b,d   Keller, Charlotte ^a,b   Starkie, Rebecca L ^c   Osada, Takuya ^a   Febbraio, Mark A ^a,c   Pedersen, Bente Klarlund ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Cytokines; Endocrine system; Exercise; Interleukins; Metabolism

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE RELEASE; EXERCISE; FEMORAL ARTERY; FEMORAL VEIN; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; KNEE FUNCTION; MALE; MUSCLE BIOPSY; MUSCLE CONTRACTION; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REST; VASTUS LATERALIS MUSCLE;

EID: 0036889057     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00255.2002     Document Type: Article

References (42)

1. Abbas AK, Lichtman AH, and Pober JS. Cellular and Molecular Immunology. Philadelphia, PA: Saunders, 1997.
2. Andersen P and Saltin B. Maximal perfusion of skeletal muscle in man. J Physiol 366: 233-249, 1985.
3. Bagby GJ, Crouch LD, and Shepherd RE. Exercise and cytokines: Spontaneous and elicited response. In: Exercise and Immune Function. New York: CRC, 1996, p. 55-78.
4. Birkenkamp KU, Esselink Mt, Kruijer W, and Wellenga E. An inhibitor of P13-K differentially affects proliferation and IL-6 protein secretion in normal and leukemic myeloid cells depending on the stage of differentiation. Exp Hematol 28: 1239-1249, 2000.
5. Blomstrand E, Radegran G, and Saltin B. Maximum rate of oxygen uptake by human skeletal muscle in relation to maximal activities of enzymes in the Krebs cycle. J Physiol 501: 455-460, 1997.
6. Camus G, Poortmans J, Nys M, Deby-Dupont G, Duchateau J, Deby C, and Lamy M. Mild endotoxaemia and the inflammatory response induced by a marathon race. Clin Sci (Colch) 92: 415-422, 1997.
7. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
8. Craig R, Larkin A, Mingo AM, Thuerauf DJ, Andrews C, McDonough PM, and Glembotski CC. p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J Biol Chem 275: 23814-23824, 2000.
9. 12 muscle cells. Am J Physiol Endocrinol Metab 276: E849-E855, 1999.
10. Greiwe JS, Cheng B, Rubin DC, Yarasheski KE, and Semenkovich CF. Resistance exercise decreases skeletal muscle tumor necrosis factor α in frail elderly humans. FASEB J 15: 475-482, 2001.
11. Halse R, Pearson SL, McCormack JG, Yeaman SJ, and Taylor R. Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells. Diabetes 50: 1102-1109, 2001.
12. Jonsdottir IH, Schjerling P, Ostrowski K, Asp S, Richter EA, and Pedersen BK. Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles. J Physiol 528: 157-163, 2000.
13. 2+ dependent pathway (Abstract). J Physiol 539P, 2002.
14. Keller C, Steensberg A, Pilegaard H, Osada T, Saltin B, Pedersen BK, and Neufer PD. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: Influence of muscle glycogen content. FASEB J 15: 2748-2750, 2001.
15. Kern PA, Ranganathan S, Li C, Wood L, and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280: E745-E751, 2001.
16. Kirwan JP, Del Aguila LF, Hernandez JM, Williamson DL, O'Gorman DJ, Lewis R, and Kirshnan RK. Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletal muscle. J Appl Physiol 88: 797-803, 2000.
17. Matthys P, Mitera T, Heremans H, Van Damme J, and Billiau A. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice. Infect Immun 63: 1158-1164, 1995.
18. Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, Satoh S, Niwa M, Senoh H, and Fujiwara H. T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 179: 1529-1537, 1994.
19. Nieman DC, Nehlsen-Cannarella SL, Fagoaga OR, Henson DA, Utter A, Davis JM, Williams F, and Butterworth DE. Influence of mode and carbohydrate on the cytokine response to heavy exertion. Med Sci Sports Exerc 30: 671-678, 1998.
20. Ostrowski K, Rohde T, Asp S, Schjerling P, and Pedersen BK. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 515: 287-291, 1999.
21. Ostrowski K, Rohde T, Zacho M, Asp S, and Pedersen BK. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 508: 949-953, 1998.
22. Pedersen BK and Hoffman-Goetz L. Exercise and the immune system: Regulation, integration, and adaptation. Physiol Rev 80: 1055-1081, 2000.
23. Pedersen BK, Steensberg A, and Schjerling P. Muscle-derived interleukin-6: Possible biological effects. J Physiol 536: 329-337, 2001.
24. Pilegaard H, Ordway GA, Saltin B, and Neufer PD. Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. Am J Physiol Endocrinol Metab 279: E806-E814, 2000.
25. Pue CA, Mortensen RF, Marsh CB, Pope HA, and Wewers MD. Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages. J Immunol 156: 1594-1600, 1996.
26. Radegran G. Ultrasound Doppler estimates of femoral artery blood flow during dynamic knee extensor exercise in humans. J Appl Physiol 83: 1383-1388, 1997.
27. Richter EA, Derave W, and Wojtaszewski JFP. Glucose, exercise and insulin: Emerging concepts. J Physiol 535: 313-322, 2001.
28. Ryder JW, Chibalin AV, and Zierath JR. Intracellular mechanisms underlying increases in glucose uptake in response to insulin or exercise in skeletal muscle. Acta Physiol Scand 171: 249-257, 2001.
29. Saghizadeh M, Ong JM, Garvey WT, Henry RR, and Kern PA. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest 97: 1111-1116, 1996.
30. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, and Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75: 40-47, 1990.
31. Starkie RL, Arkinstall MJ, Koukoulas I, Hawley JA, and Febbraio MA. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol 533: 585-591, 2001.
32. Starkie RL, Rolland J, Angus DJ, Anderson MJ, and Febbraio MA. Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after prolonged running. Am J Physiol Cell Physiol 280: C769-C774, 2001.
33. Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B, and Pedersen BK. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 537: 633-639, 2001.
34. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, and Klarlund PB. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529: 237-242, 2000.
35. Tanaka T, Kanda T, McManus BM, Kanai H, Akiyama H, Sekiguchi K, Yokoyama T, and Kurabayashi M. Overexpression of interleukin-6 aggravates viral myocarditis: Impaired increase in tumor necrosis factor-alpha. J Mol Cell Cardiol 33: 1627-1635, 2001.
36. Tilg H, Dinarello CA, and Mier JW. IL-6 and APPs: antiinflammatory and immunosuppressive mediators. Immunol Today 18: 428-432, 1997.
37. Toft AD, Jensen LB, Bruunsgaard H, Ibfelt T, Halkjaer-Kristensen J, Febbraio MA, and Pedersen BK. Cytokine response to eccentric exercise in young and elderly humans. Am J Physiol Cell Physiol 283: C289-C295, 2002.
38. Toft AD, Thorn M, Ostrowski K, Asp S, Moller K, Iversen S, Hermann C, Sondergaard SR, and Pedersen BK. N-3 polyunsaturated fatty acids do not affect cytokine response to strenuous exercise. J Appl Physiol 89: 2401-2406, 2000.
39. Uysal KT, Wiesbrock SM, Marino MW, and Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389: 610-614, 1997.
40. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, and Jansson JO. Interleukin-6-deficient mice develop mature-onset obesity. Nature Med 8: 75-79, 2002.
41. Yamauchi-Takihara K and Kishimoto T. Cytokines and their receptors in cardiovascular diseases - Role of gp130 signalling pathway in cardiac myocyte growth and maintenance. J Exp Pathol 81: 1-16, 2000.
42. Youd JM, Rattigan S, and Clark MG. Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. Diabetes 49: 1904-1909, 2000.